Transcenta Announces the Appointment of Daniel Weng as CFO

Transcenta Holding Limited (“Transcenta”) (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody …
( read original story …)

---